Association of Genetic Variation of Sodium Taurocholate Cotransporting Polypeptide with Chronic Hepatitis B Virus Infection
Authors:
- 1 June 2014
- journal article
- research article
- Published by SAGE Publications in Genetic Testing and Molecular Biomarkers
- Vol. 18 (6) , 425-429
Abstract
Background: Sodium taurocholate cotransporting polypeptide (NTCP) plays an important role in the enterohepatic circulation of bile acids and hepatocyte function and was recently proposed to be a functional receptor for hepatitis B virus (HBV). Objective: This study investigated the association of the functional polymorphism c.800C>T (p.S267F) (rs2296651) of the NTCP gene with HBV infection. Methods: The study included 244 patients with chronic HBV infection, 76 HBV infection resolvers, and 113 healthy controls. The polymorphism was genotyped using the polymerase chain reaction–restriction fragment length polymorphism method. Results: The distribution of the genotype and allele frequency of rs2296651 polymorphism was significantly different among the HBV patients, HBV infection resolvers, and healthy controls (p=0.034 and p=0.039, respectively). The frequency of genotype CT in HBV patients was significantly higher than that in healthy controls (11.9% vs. 4.4%, p=0.026, odds ratios [OR]=2.913, 95% confidence intervals [95% CI]=1.097–7.738). The frequency of allele T in HBV patients was also significantly higher than that in healthy controls (5.9% vs. 2.2%, p=0.029, OR=2.793, 95% CI=1.067–7.312). The frequency of genotype CT and allele T in HBV patients was higher than that in HBV infection resolvers although the difference was not significant. The genotype and allele frequency between infection resolvers and healthy controls and between HBV patients with different clinical diseases had no significant difference. Conclusion: These findings suggest that the rs2296651 polymorphism may predispose the susceptibility to and chronicity of HBV infection.Keywords
This publication has 22 references indexed in Scilit:
- Genetic polymorphisms in Na+-taurocholate co-transporting polypeptide (NTCP) and ileal apical sodium-dependent bile acid transporter (ASBT) and ethnic comparisons of functional variants of NTCP among Asian populationsXenobiotica, 2011
- Global Epidemiology of Hepatitis B Virus (HBV) InfectionAmerican Chinese Journal of Medicine and Science, 2011
- Differential effect of genetic variants of Na+-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitorsXenobiotica, 2010
- HBV pathogenesis in animal models: Recent advances on the role of plateletsJournal of Hepatology, 2007
- The immune response during hepatitis B virus infectionJournal of General Virology, 2006
- Drug and Bile Acid Transporters in Rosuvastatin Hepatic Uptake: Function, Expression, and PharmacogeneticsGastroenterology, 2006
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Hepatitis B Virus Infection — Natural History and Clinical ConsequencesNew England Journal of Medicine, 2004
- Ethnicity-dependent Polymorphism in Na+-taurocholate Cotransporting Polypeptide (SLC10A1) Reveals a Domain Critical for Bile Acid Substrate RecognitionJournal of Biological Chemistry, 2004
- Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter.Journal of Clinical Investigation, 1994